Table 1 Baseline demographics and clinical characteristics of the study patients
Total population (n = 1140) | Lower GA (≤ 14.10%, n = 576) | Higher GA (> 14.10%, n = 564) | P value | |
|---|---|---|---|---|
Demographics | ||||
Age, years | 59.55 ± 10.98 | 56.37 ± 11.00 | 62.80 ± 10.00 | < 0.001 |
Sex, male, n (%) | 704 (61.8) | 379 (65.8) | 325 (57.6) | 0.005 |
BMI, kg/m2 | 25.01 ± 3.24 | 25.37 ± 3.33 | 24.64 ± 3.10 | < 0.001 |
Heart rate, bpm | 69.67 ± 12.42 | 69.44 ± 11.58 | 69.90 ± 13.23 | 0.535 |
SBP, mmHg | 125.78 ± 15.43 | 125.12 ± 14.82 | 126.46 ± 16.01 | 0.142 |
DBP, mmHg | 75.89 ± 10.48 | 76.44 ± 10.33 | 75.33 ± 10.61 | 0.072 |
Clinical diagnosis, n (%) | ||||
UAP | 830 (72.8) | 426 (74.0) | 404 (71.6) | 0.377 |
NSTEMI | 147 (12.9) | 76 (13.2) | 71 (12.6) | 0.760 |
STEMI | 163 (14.3) | 74 (12.8) | 89 (15.8) | 0.157 |
Echocardiographic findings | ||||
LVEF, % | 61.59 ± 8.21 | 62.20 ± 7.42 | 61.01 ± 8.87 | 0.023 |
Laboratory test | ||||
Creatinine, umol/L | 69.62 ± 29.36 | 68.84 ± 14.27 | 70.42 ± 39.14 | 0.385 |
TC, mmol/L | 3.96 ± 0.68 | 3.97 ± 0.67 | 3.95 ± 0.68 | 0.710 |
TG, mmol/L | 1.47 ± 0.86 | 1.54 ± 0.82 | 1.39 ± 0.91 | 0.003 |
LDL-c, mmol/L | 2.28 ± 0.58 | 2.29 ± 0.58 | 2.26 ± 0.58 | 0.412 |
HDL-c, mmol/L | 1.15 ± 0.28 | 1.13 ± 0.27 | 1.17 ± 0.30 | 0.006 |
FBG, mmol/L | 5.78 ± 1.59 | 5.44 ± 1.05 | 6.13 ± 1.93 | < 0.001 |
SA, g/L | 42.70 ± 3.68 | 42.68 ± 3.23 | 42.73 ± 4.07 | 0.822 |
UA, umol/L | 328.31 ± 84.60 | 337.50 ± 88.85 | 319.05 ± 79.10 | < 0.001 |
hs-CRP, mg/L | 1.20[0.53, 3.17] | 1.20[0.56, 3.00] | 1.20[0.48, 3.56] | 0.808 |
CK, U/L | 82.00[57.00, 121.25] | 81.00[58.00, 116.00] | 83.00[57.00, 126.00] | 0.403 |
GA, % | 14.37 ± 2.42 | 12.91 ± 0.85 | 15.87 ± 2.59 | < 0.001 |
Angiography, n (%) | ||||
Left main | 64 (5.6) | 33 (5.7) | 31 (5.5) | 0.864 |
Left anterior descending | 830 (72.8) | 425 (73.8) | 405 (71.8) | 0.453 |
Circumflex | 416 (36.5) | 209 (36.3) | 207 (36.7) | 0.884 |
Right coronary artery | 460 (40.4) | 225 (39.1) | 235 (41.7) | 0.370 |
Single-vessel disease | 599 (52.5) | 302 (52.4) | 297 (52.7) | 0.938 |
Multi-vessel disease | 474 (41.6) | 239 (41.5) | 235 (41.7) | 0.953 |
Treatment, n (%) | ||||
Revascularization | 846 (74.2) | 436 (75.7) | 410 (72.7) | 0.247 |
PCI | 765 (67.1) | 395 (68.6) | 370 (65.6) | 0.285 |
CABG | 81 (7.1) | 41 (7.1) | 40 (7.1) | 0.986 |
Medication | 294 (25.8) | 140 (24.3) | 154 (27.3) | 0.247 |
Discharge medication, n (%) | ||||
Aspirin | 1086 (95.3) | 553 (96.0) | 533 (94.5) | 0.232 |
P2Y12 inhibitors | 992 (87.0) | 509 (88.4) | 483 (85.6) | 0.170 |
Statins | 1095 (96.1) | 548 (95.1) | 547 (97.0) | 0.109 |
ACEI/ARBs | 114 (10.0) | 50 (8.7) | 64 (11.3) | 0.133 |
Beta blockers | 668 (58.6) | 331 (57.5) | 337 (59.8) | 0.433 |